Painless Obstructive Jaundice Investigations Blood Results - PowerPoint PPT Presentation

1 / 37
About This Presentation
Title:

Painless Obstructive Jaundice Investigations Blood Results

Description:

Painless Obstructive Jaundice Investigations Blood Results Further investigations Slide 13 Slide 14 Slide 15 Summary Pancreatic Cancer Management Slide 19 ... – PowerPoint PPT presentation

Number of Views:378
Avg rating:3.0/5.0
Slides: 38
Provided by: cmftNhsUk
Category:

less

Transcript and Presenter's Notes

Title: Painless Obstructive Jaundice Investigations Blood Results


1
Jaundice by Billy Rubin PBL 4
2
Overview
  • Case presentation
  • Differential Diagnosis
  • Surgical Management
  • Medical Management
  • Questions

3
Case Presentation
  • 77 year old female
  • Retired seamstress
  • Lives at home with husband

4
Presenting Complaint
  • Jaundice

5
  • HxPC
  • Pruritus
  • Dark urine
  • Pale stools
  • No pain
  • Heaviness in epigastrium

6
  • PMHx
  • Bowel cancer 1985
  • Hysterectomy 1985
  • DHx
  • No regular medication
  • NKDA
  • SHx
  • Does not smoke or drink
  • Lives at home with husband
  • FHx
  • None

7
Examination
  • Jaundice
  • Epigastric tenderness
  • Fullness in the epigastrium
  • No palpable lymph nodes
  • No organomegaly

8
Differential diagnosis of jaundice?
  • Prehepatic
  • Sickle Cell disease
  • Haemolytic anaemia
  • Drug side effects
  • Blood transfusion
  • Hepatic
  • Hepatitis
  • Cirrhosis
  • Ca liver
  • Post hepatic
  • Cholangitis
  • Cholelithiasis
  • Acalculus
  • Ca of pancreas
  • Cholangio-carcinoma

9
Painless Obstructive Jaundice
  • Cholangiocarcinoma
  • Ca head of pancreas
  • Gallstones

10
Investigations
  • Full blood count
  • Urea and electrolytes
  • Liver function tests
  • Amylase
  • Clotting screen
  • CRP

11
Blood Results
  • LFT
  • Bilirubin 252 (3-17micromol/L)
  • ALT 352 (3-35iu/L)
  • ALP 178 (25-110iu/L)
  • GGT 440 (lt65iu/L)
  • Clotting screen
  • PT 10.9s
  • aPPT 25.8s (24.6-34.9)
  • INR lt1
  • CRP lt 3
  • FBC
  • Hb 12.6 (11.5-16.5g/dL)
  • WCC 3.9 (4-11x109/L)
  • Platelets 276 (150-400x109/L)
  • UEs
  • Na 139 (135-145mmol/L)
  • H 3.7
  • Urea 3.6 (2.5-6.7mmol/L)
  • Creatinine 44 (70-150ymol/L)
  • eGFR gt90 (100-130 ml/min)

12
Further investigations
  • CT/ USS
  • ERCP

13
(No Transcript)
14
(No Transcript)
15
(No Transcript)
16
Summary
  • 77 y/o woman
  • Painless obstructive jaundice
  • Ca head of pancreas
  • Unresectable
  • Palliative care

17
Pancreatic Cancer
  • In the UK lt 2 of malignancies and 5000 deaths/yr
  • MaleFemale 21
  • Aetiology Smoking, alcohol, industrial agents
  • 95 are ductal adenocarcinomas
  • 70 head of pancreas
  • 5 year-survival lt5
  • Median survival is 3-6 months
  • Symptoms obstructive jaundice, pruritis,
    epigastric pain, weight loss
  • Diabetes and malabsorption

18
Management
19
(No Transcript)
20
Surgical management of pancreatic cancer
  • Pancreaticoduodenectomy
  • Classic Whipples procedure
  • Pylorus-preserving pancreaticoduodenectomy (PPPD)
  • Indications
  • Ca head of pancreas, carcinoid tumour, chronic
    pancreatitis, Klatskin tumour, traumatic injury
  • Very complex procedure!

21
Exposure
  • Patient supine
  • Upper midline incision
  • Subcutaneous dissection and division of rectus
    abdominis

22
Search for metastases
  • Liver
  • Lymph nodes
  • Adjacent vessels
  • Bowel
  • Peritoneum

23
4 cuts
  • Cholecystectomy/ biliary tree
  • Hemigastrectomy (classic)
  • Pancreatectomy at junction between neck and body
    send sample of body for histology
  • Divide jejunum distal to ligament of Treinz

24
Resection specimen
25
Join up!
  • Pancreaticojejunostomy
  • Gastrojejunostomy
  • Hepaticojejunostomy

26
Classic Whipples procedure with gastrojejunostomy
27
Pylorus-preserving pancreaticoduodenectomy (PPPD)
28
Vulnerable structures
  • Close proximity to major vessels IVC and
    superior mesenteric vessels
  • BEWARE ANATOMICAL ANOMALIES replaced common
    hepatic artery or replaced right hepatic artery

29
Complications
  • Blood loss
  • Leaking from anastomoses
  • Gastroparesis
  • Diabetes

30
Outcome of procedure
  • 5 year survival - 20 with Whipples (may rise to
    40 if lymph nodes not involved) compared with 5
    on chemotherapy alone.
  • Mortality lt 5

31
Surgical Contraindications
  • Three main concerns
  • Patient not fit for surgery
  • Metastatic disease
  • Un-resectable tumors

32
(No Transcript)
33
The future?
  • Laparoscopic pancreaticoduodenectomy
  • Many retrospective studies ongoing
  • Issues with operating time and technical
    difficulty

34
Palliative Care
  • Pain management is of paramount importance
  • Radiotherapy
  • Chemotherapy
  • Stenting
  • Treatment of exocrine or endocrine insufficiency

35
Liverpool Care Pathway
  • The gold standard care pathway for patients
    diagnosed as dying by an MDT
  • Patients needs are assessed on their individual
    circumstances
  • Symptom management ensuring patients quality of
    life
  • Anticipatory prescribing is essential

36
References
  • Oxford Handbook of Clinical Medicine
  • Clinical Surgery, M. Henry, Johnson
  • http//www.bcdecker.com/SampleOfChapter/1550092707
    .pdf

37
Thank You
Write a Comment
User Comments (0)
About PowerShow.com